文献速递鼻科头颈外科

鼻窦癌现代多学科管理的长期结局:M. D. Anderson经验

Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience.
PubMed 文献 · Head Neck · 2023-05-10

回顾性分析311例接受调强放疗或质子治疗的鼻窦肿瘤患者,中位随访75个月,最常见组织学为鳞状细胞癌(42%)、腺样囊性癌(15%)和鼻窦未分化癌(15%)。10年局部控制率、区域控制率、无远处转移生存率、无进展生存率和总生存率分别为73%、88%、47%、32%和51%,晚期≥3级毒性发生率为13%。

要点

  • 10年局部控制率73%、区域控制率88%、无远处转移生存率47%、无进展生存率32%、总生存率51%。
  • 年龄、非鼻腔肿瘤部位、T3-4分期、颈清扫和放疗剂量可预测无进展生存。
  • 年龄、非鼻腔肿瘤部位、T3-4分期、切缘阳性、颈清扫和新辅助化疗可预测总生存。

核心结论

  • 该鼻窦癌队列接受现代放疗后显示出良好的疾病控制率和可接受的毒性特征。

研究设计与样本

  • 回顾性分析接受调强放疗或质子治疗的鼻窦肿瘤患者。
  • 共纳入311例患者,中位随访75个月。

主要发现

  • 最常见组织学为鳞状细胞癌(42%)、腺样囊性癌(15%)和鼻窦未分化癌(15%)。
  • 47%患者接受诱导化疗,68%接受辅助放疗。
  • 10年局部控制率73%、区域控制率88%、无远处转移生存率47%、无进展生存率32%、总生存率51%。
  • 年龄、非鼻腔肿瘤部位、T3-4分期、颈清扫和放疗剂量可预测无进展生存。
  • 年龄、非鼻腔肿瘤部位、T3-4分期、切缘阳性、颈清扫和新辅助化疗可预测总生存。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report long-term outcomes of modern radiotherapy for sinonasal cancers. METHODS AND MATERIALS: A retrospective analysis of patients with sinonasal tumors treated with intensity-modulated radiotherapy or proton therapy. Multivariate analysis was used to determine predictive variables of progression free survival (PFS) and overall survival (OS). RESULTS: Three hundred and eleven patients were included, with median follow-up of 75 months. The most common histologies were squamous cell (42%), adenoid cystic (15%), and sinonasal undifferentiated carcinoma (15%). Induction chemotherapy was administered to 47% of patients; 68% had adjuvant radiotherapy. Ten-year local control, regional control, distant metastasis free survival, PFS, and overall survival rates were 73%, 88%, 47%, 32%, and 51%, respectively. Age, non-nasal cavity tumor site, T3-4 stage, neck dissection, and radiation dose were predictive of PFS, while age, non-nasal cavity tumor site, T3-4 stage, positive margins, neck dissection, and use of neoadjuvant chemotherapy were predictive of OS. There was a 13% rate of late grade ≥3 toxicities. CONCLUSION: This cohort of patients with sinonasal cancer treated with modern radiotherapy demonstrates favorable disease control rate and acceptable toxicity profile.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Bahig H, Ehab HY, Garden AS, et al. Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience. Head Neck. 2023. PMID: 37165701. doi:10.1002/hed.27381

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。